- Dental implant provider lands growth investment
- Specialty1 Partners appoints VP of business development
- ‘Much needed clarity and a path to restore trust’: Fairview, U of Minnesota, M Physicians close in on new 10-year deal
- Maryland dental practice acquires 2nd office
- Physicians are not ‘providers’: AMA
- Stanford’s AI discharge summary tool cuts physician burnout
- Optum to cut 92 jobs in California
- R1 RCM names former Humana executive CIO
- 2 Oregon practices merge, creating one of state’s largest physician-owned groups
- 3 states take aim at private equity in healthcare
- UPMC lays off 200 workers, cuts 300 positions
- Google develops passive heart rate monitoring via smartphone camera
- Why AdventHealth thinks it can sell an internal insurance model to employers
- AHA: Hospitals lean on technology to make healthcare more affordable
- How Oceans Healthcare is scaling behavioral care — starting with the ER
- South Dakota health system names 2 executives
- 5 ASC leaders to know
- GLP-1 drugs tied to 75% lower substance use disorder odds: 4 notes
- When physician groups hit the wall: 3 turnaround stories
- 7 updates from Park Dental Partners since its IPO
- House Appropriations Committee takes aim at CMS' WISeR pilot
- How general dentist pay compares to 25 healthcare roles
- 14 state behavioral health policy updates
- Who’s snatching up DSOs?
- The missed colonoscopy problem ASCs can no longer afford to ignore
- PCMA unveils new policy platform aimed at drug affordability
- DEA finalizes OUD treatment rule: What it means for behavioral healthcare
- CalOptima Health approves $430M rate increase to keep safety-net providers afloat
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- HCA Surgery Ventures names supply chain CEO
- 15 neurosurgeons to know
- CRNA pay is up 59% since 2019: 5 reasons why
- GLP-1s tied to lower risk of multiple cancers
- University of Pittsburgh dental school to open 3rd training center
- Colorado ‘screened out’ 92% of youth center abuse hotline calls: 5 things to know
- ASCs’ hidden efficiency drain
- Dental College of Georgia dean dies
- SF General, UCSF fined after social worker’s fatal stabbing
- Penn Medicine ED program boosts naltrexone prescriptions 15-fold
- Hundreds of hospitals warned over price transparency failings, AP reports
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- Cleveland Clinic agrees to 'decades-long' halt on gender-affirming care for minors in DOJ settlement
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals
- Clinicians report AI use expands patient capacity, boosts efficiency: Philips survey
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AstraZeneca reprimanded over LinkedIn likes once again
- FDA Expands Sunscreen Options for the First Time in 20 Years
- 29 behavioral health executive moves to know
- 3 states where dental hygienist pay dropped
- 5 states where dental assistant pay dropped
- ‘No disruptions’: Elevance study backs take-home methadone
- Dartmouth Health targets treatment gap for pregnant patients with SUD
- From affordability to engagement, these are the topics to watch at AHIP 2026
- Accrediting bodies, more medical schools commit to RFK Jr.'s nutrition education pledge
- Children's Well-Being Plummets Across 29 States, Report Finds
- Senate HELP committee chairman seeks info on NYC Health + Hospital data breach
- ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes
- With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race
- CVS launched an AI Learning Academy for its workforce. Here's why
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Sophia Genetics, Memorial Sloan Kettering sign strategic collab for AI-powered precision oncology hub
- ‘Law & Order’ star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Cities sue Trump administration to block final ACA rule
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi
- Upcoming Billing Change Could Make Pregnancy Pricier
- MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy
- By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying
- Hikma earmarks $267M to expand pair of Ohio production sites, add 350 jobs
- Stepful banks $55M to scale AI-powered medical training to boost the workforce pipeline
- ADA: Amgen highlights Repatha perks, GLP-1 pitfalls in push to boost cardiometabolic pedigree
- Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
- Untreated Cancer, Festering Infections: Immigrant Detainees Detail Medical Care Lapses
- Elation Health acquires Aster as it ramps up agentic AI for primary care
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Essence Healthcare, Oura expand partnership to sleep apnea detection
- Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
- Industry Voices—A healthcare experience that is as seamless as it is soulful
- Fullspan Health debuts Healthline AI companion to connect consumers to medical content and providers
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- Behind the headlines of ASCO 2026
- RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines
- Two-Pill Combo, Inqovi and Venclexta, Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
- ‘We Live With Fear’: In Congo, Doctors Face Ebola With Little Protection
- Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite
- Upcoming Billing Change Could Make Pregnancy Pricier
- At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Weekly Rundown: Trump signs AI executive order; Health Catalyst to sell Vitalware for $147M
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
- Remarks at the Investor Advisory Committee Meeting
- Fierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
- ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta
- As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Axsome fends off generic competition to narcolepsy med Sunosi until 2040
- Menopause Hormone Therapy Use Drops Sharply Across United States
- Michigan Found A Way To Reduce School Vaccine Waivers — Until It Backfired
- Listen to the Latest ‘KFF Health News Minute’
- 8 Requirements for AI Medical Interpreting: 2026 Survey Results
- Healthcare Dealmakers—WakeMed to join Atrium Health, Qualtrics closes $6.8B Press Ganey deal and more
- Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
- Just 90 Minutes Of Strength Training A Week Linked To Longer Life
- Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
- Urine Test Can Detect Autism, Study Says
- High-Puff Vapes Become More Toxic Over Time, Study Says
- GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
- Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
- Base Case: Remarks at the IC3 Blockchain Camp
- Trump Signs Order Calling For Fewer Childhood Vaccines
- Simple Blood Test May Help Detect And Stage Alzheimer's Disease
- Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
- Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- CAT on a Hot Tin Roof
Michigan healthcare freedom community forum
The Centers for Medicare & Medicaid Services (CMS) is almost hopelessly behind in their Medicare Advantage (MA) plan audits, going back to payment year (PY)2018. The new CMS Director, Dr. Mehmet OZ, has directed CMS to audit all eligible MA contracts for each payment year and will invest additional resources to expedite the completion of audits for payment years 2018 through 2024. The savings from these audits should cover their costs:
Dr. Oz Must Tackle MA Fraud, One Insurer at a Time
By Marion Mass - June 09, 2025CMS Director Mehmet Oz just directed the agency to double down on auditing Medicare Advantage (MA) plans to root out waste and fraud. In the same week, Senate Republicans signalled the same scrutiny. Americans should be cheering these moves that could keep Medicare sustainable.
For years, lawmakers and agencies like CMS alike have seen evidence that MA plan insurers routinely overcharge the government by billions, leaving the average taxpayer to foot the bill. This fraud is unacceptable – and it’s just for Congress and the Administration to stomp it out.
Starting with this audit, Director Oz ought to send a clear message to insurers that have practiced rampant abuse of taxpayer dollars: We have zero tolerance for fraud, waste, and abuse.
Medicare Advantage, when created, allowed Medicare patients to have a choice of a private coverage option. But the very makeup of these plans invite insurers to game the system.
Private insurers that run MA plans will take any chance they can to increase their margins and bleed Medicare dry. Countless MA insurers charged the government for diagnoses based on shoddy health screening done in-house, according to a 2021 Inspector General’s report. It’s not a new problem, either – MA overbilling goes back to 2012, when CMS found $12 billion of this fraud under the Obama administration.
The fraud has only ballooned since then. Today, MA insurers bill $140 billion in excess of what treatments were required for U.S. patients, according to the Center for Medicare Advocacy. Some health plans over-bill by up to $5,888 per patient for standard treatments.
Should Americans expect this additional cash flow to go to patients? Of course not. Nearly one-third of all American healthcare expenditures go to administrative costs and fees, according to a survey from the Commonwealth Fund. That means more money towards suits and less to the ‘scrubs’ helping the patients.
The government must take a stand against this misuse of funds. CMS Director Oz is starting now. Here’s a few pointed suggestions.
CMS needs to step in at the root of the problem: “Upcoding.” Medicare Advantage patients are diagnosed with more severe conditions than they actually have, if they even have them at all. The result is a much larger check for the insurers running the MA plans, coming right out of the coffers of American taxpayers.
The worst offenses happen outside the doctor’s office. Insurers often send non-physician employees to patients’ homes, administer “Health Risk Assessments”, which results in the upcoding. United Healthcare, who runs more MA plans and who stands accused of upcoding more than any than any other insurer, employs or is associated with 10% of America’s practicing physicians. It’s hard to imagine that this perverse incentive has not been used by United to help their bottom line.
CMS Director Oz should work with lawmakers to bar insurers from upcoding and mandate that actual non-conflicted physicians perform screenings for insurance purposes. These two simple changes could prevent insurers from ripping off the government – and the government can prevent these insurers from mishandling millions of patients’ illnesses.
Dr. Oz would be wise to have CMS broadcast exactly which insurers are responsible for upcoding, so Americans interested in purchasing Medicare Advantage plans can make well informed choices.
Lastly, large insurance company subsidiaries have a history of unfairly clawing back money in the pharmacy space. Any fraudulently collected upcoded money must be clawed back with deserved impunity.
It’s more important than ever to start now. More than 40 million Americans are expected to enroll in MA plans by 2030. Insurers must be thrilled at the growing opportunity to defraud the government, but policymakers are worried. The more seniors and at-risk patients enrolled in MA plans, the more that lawmakers need to control costs without denying care. Banning practices like upcoding and Health Risk Assessments prevent these costs from spiraling.
Director Oz has in the past been an outspoken advocate for Medicare Advantage. Yet while Oz’s opponents called him out for pushing pro-insurance talking points, this audit shows that he’s anything but a shill. Taking MA reforms a step further allows him make good on his promise to “stop unscrupulous people from stealing from vulnerable Americans.” He and CMS as a whole must hold insurers accountable for their actions to make Medicare as solvent as it can be.
Auditing insurers is a great place to start – but it’s only a start. To fully eradicate this waste, fraud, and abuse, CMS needs to back up its words with actions.
Marion Mass, M.D. is a Bucks County, PA pediatrician and the co-founder of the Practicing Physicians of America.
The CMS Medicare Advantage Audit Press Release:
CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits
Agency Will Begin Auditing All Eligible Medicare Advantage Contracts Each Payment Year and Add Resources to Expedite Completion of 2018 to 2024 AuditsMay 25, 2025
Today, the Centers for Medicare & Medicaid Services (CMS) announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans. Beginning immediately, CMS will audit all eligible MA contracts for each payment year in all newly initiated audits and invest additional resources to expedite the completion of audits for payment years 2018 through 2024.
“We are committed to crushing fraud, waste and abuse across all federal healthcare programs,” said Dr. Mehmet Oz, CMS Administrator. “While the Administration values the work that Medicare Advantage plans do, it is time CMS faithfully executes its duty to audit these plans and ensure they are billing the government accurately for the coverage they provide to Medicare patients.”
Medicare Advantage plans receive risk-adjusted payments based on the diagnoses they submit for enrollees—meaning higher payments for patients with more serious or chronic conditions. To verify the accuracy of these claims, CMS conducts Risk Adjustment Data Validation (RADV) audits to confirm that diagnoses used for payment are supported by medical records.
Currently, CMS is several years behind in completing these audits. The last significant recovery of MA overpayments occurred following the audit of payment year (PY) 2007, despite federal estimates suggesting MA plans may overbill the government by approximately $17 billion annually. The Medicare Payment Advisory Commission (MedPAC) estimates this figure could be as high as $43 billion per year. CMS’s completed audits for PYs 2011–2013 found between 5% and 8% in overpayments.
To address this backlog, the Trump Administration has introduced a plan to complete all remaining RADV audits for PY 2018 to PY 2024 by early 2026. Key elements of the plan include:
Enhanced Technology: CMS will deploy advanced systems to efficiently review medical records and flag unsupported diagnoses.
Workforce Expansion: CMS will increase its team of medical coders from 40 to approximately 2,000 by September 1, 2025. These coders will manually verify flagged diagnoses to ensure accuracy.
Increased Audit Volume: By leveraging technology, CMS will be able to increase its audits from ~60 MA plans a year to all eligible MA plans each year in all newly initiated audits (approximately 550 MA plans). CMS will also be able to increase from auditing 35 records per health plan per year to between 35 and 200 records per health plan per year in all newly initiated audits based on the size of the health plan. This will help ensure CMS’s audit findings are more reliable and can be appropriately extrapolated as allowed under the RADV final rule.
In addition to these efforts, CMS will collaborate with the Department of Health and Human Services Office of Inspector General (HHS-OIG) to recover uncollected overpayments identified in past audits. CMS reaffirms its commitment to ensuring all Medicare Advantage plans comply with federal requirements and accurately report patient diagnoses used for payment.
It appears that AHIP has enough Republican U.S. Senators kowtowing to kill off any changes in Medicare Advantage. Dr. Oz will certainly get the message:
Republicans back off Medicare changes in GOP megabill
An effort to get savings from reforms to popular Medicare Advantage plans is failing to gain ground in the Senate.By Jordain Carney and Robert King - June 10, 2025
Senate Republicans appear to be popping their own trial balloon on including changes to Medicare as part of their “big beautiful bill.”
The public shift comes after GOP senators caught their own colleagues off guard — and gave Democrats a new political target — when they opened the door last week to going after “waste, fraud and abuse” within the program to capture savings to satisfy their deficit hawks.
But Sen. Kevin Cramer (R-N.D.), who raised the concept after a closed-door conference meeting last week, said in a brief interview Tuesday that he now doesn’t expect Republicans to actually grab one of their third rails as an offset for President Donald Trump’s sweeping megabill.
When asked if he expects Medicare changes to make it into the massive tax and spending package, Cramer replied, “I don’t know that I do. There aren’t many of us courageous enough to talk about it.” He also acknowledged that his previous remarks sparked “a lot of angst.”
Republicans also last week floated potentially including bipartisan legislation from Sens. Bill Cassidy (R-La.) and Jeff Merkley (D-Ore.) that would target overpayment in Medicare Advantage plans, which enables older Americans to buy private plans offering health coverage. It could lead to tens of billions of dollars in savings.
Many GOP senators, however, raised concerns publicly and privately about including language from that bill as part of the larger tax and spending package.
Sen. Josh Hawley (R-Mo.) said Tuesday he’d spoken with Trump directly and the president wasn’t in favor of doing anything on Medicare.
“He said people who play around with Medicare lose elections,” Hawley said.
The major insurance industry group AHIP also weighed in, warning that the bill would lead to higher costs and reductions in benefits. Moderates in the House also sounded the alarm bells that Senate Republicans appeared to be reviving an idea they had earlier rejected as a pay-for in their version of the legislation.
Even members of the Senate Finance Committee poured cold water on the likelihood that it would be included in draft text their panel could release as soon as Friday. The pushback isn’t based on opposition to the proposal itself but questions about if the megabill is the right venue to advance this particular policy.
“There is a lot of work to be done to make sure you don’t have unintended consequences. But I think that is an area for longer-term gain. I don’t know that you can necessarily, in the horizon that we’re operating [in], be able to book some of the savings that may be out there,” said Sen. Thom Tillis (R-N.C.) about the Cassidy-Merkley measure specifically.
Asked if he expected it would be included in the legislation, Sen. John Barrasso (R-Wyo.), the Senate majority whip and a member of the Finance Committee, instead said it would be in the conference’s “discussions.”
Republicans will meet Wednesday to receive a briefing by GOP senators crafting outstanding portions of the bill, including Finance Chair Mike Crapo (R-Idaho).
Cassidy’s office did not immediately return a request for comment on the status of discussions around his policy proposal, but he has previously said his legislation does not cut benefits. Rather, he has argued it would remove tools that Medicare Advantage plans employ to garner higher payments from the federal government by making patients appear sicker than they actually are.
“This addresses an issue both Republicans and Democrats have called waste, fraud and abuse,” Cassidy said Friday.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















